BRIEF-Biogen announces additional members of management team of hemophilia spin-off company Bioverativ

* Biogen Inc - Appoints Rogerio Vivaldi, M.D. EVP and chief

global therapeutic operations officer, and John T. Greene, EVP

and chief financial officer

Read more